- Report
- October 2021
- 47 Pages
Global
- Report
- October 2021
- 39 Pages
Global
- Training
- October 2021
- 1 Day
Latin America
From €1140EUR$1,299USD£986GBP
- Report
- October 2021
Global
€10970EUR$12,500USD£9,492GBP
- Report
- July 2021
- 128 Pages
Global
From €3510EUR$4,000USD£3,037GBP
- Report
- June 2021
- 675 Pages
Global
From €3730EUR$4,250USD£3,227GBP
- Report
- April 2021
- 9 Pages
Global
€1536EUR$1,750USD£1,329GBP
- Training
- March 2021
- 2 Days
Global
From €1667EUR$1,899USD£1,442GBP
- Report
- March 2021
- 137 Pages
Global
From €4300EUR$4,900USD£3,721GBP
- Report
- February 2021
- 80 Pages
India
From €731EUR$833USD£633GBP
€1044EUR$1,190USD£904GBP
- Report
- January 2021
- 109 Pages
Global
€3990EUR$4,870USD£3,573GBP
- Report
- December 2020
- 20 Pages
United States
€1360EUR$1,550USD£1,177GBP
- Report
- October 2020
- 57 Pages
Global
- Report
- September 2020
- 700 Pages
Global
From €4300EUR$4,900USD£3,721GBP
- Report
- September 2020
- 55 Pages
United States
From €792EUR$903USD£686GBP
€1132EUR$1,290USD£980GBP
- Report
- April 2020
- 165 Pages
Global
From €854EUR$973USD£739GBP
€1220EUR$1,390USD£1,055GBP
- Report
- January 2020
United States
From €854EUR$973USD£739GBP
€1220EUR$1,390USD£1,055GBP
- Report
- January 2020
- 156 Pages
Japan
From €3949EUR$4,500USD£3,417GBP
- Drug Pipelines
- January 2020
- 1500 Pages
Global
From €2633EUR$3,000USD£2,278GBP
- Report
- September 2019
- 13 Pages
Global
€8776EUR$10,000USD£7,593GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more